Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

IntroductionSurvival rates for early-stage non-small cell lung cancer (NSCLC) remain poor despite the decade-long established standard of surgical resection and systemic adjuvant therapy. Realizing this, researchers are exploring novel therapeutic targets and deploying neoadjuvant therapies to predi...

Full description

Bibliographic Details
Main Authors: Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant
preoperative
NSCLC
systemic therapy
immunotherapy
chemoimmunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1286104/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1286104/full

Similar Items